NRIX: Nurix Therapeutics Inc

12.42 USD 0.08 (0.65%)

Setor: Cuidados de saúde Base: US Dollar Moeda de lucro: US Dollar

A taxa do NRIX para hoje mudou para 0.65%. Paralelamente, o preço mais baixo no mercado atingiu 12.06 e o mais alto foi 12.60.

Veja a dinâmica do par de moedas Nurix Therapeutics Inc. As cotações em tempo real ajudam a reagir rapidamente aos movimentos do mercado. Ao alternar entre os diferentes períodos de tempo, você pode monitorar tendências e movimentos de preços por minuto, hora, dia, semana ou mês. Use estas informações para prever os movimentos do mercado e tomar decisões de negociação informadas.

Tela cheia

NRIX Notícias

Investing 14:58 Morgan Stanley lowers Nurix stock price target to $16 on higher spend
TipRanks 17:03 Top 3 Trending Stocks, According to Analysts – 7/11/2025 - TipRanks.com
Investing 12:12 Stifel maintains Buy rating on Nurix stock, sees $4.5B peak sales potential
Investing 11:35 Nurix stock price target lowered to $26 by UBS on increased OpEx
Investing 11:14 Goldman Sachs initiates Nurix stock with Buy rating, $182 price target
Investing 11:04 Stifel reiterates Buy rating on Nurix stock, sees $4.5B peak sales potential
Investing 00:02 Nurix earnings beat by $0.19, revenue topped estimates
Investing 20:19 Nurix Therapeutics beats quarterly expectations on strong collaboration revenue
Investing 11:45 Nurix stock maintains Buy rating at H.C. Wainwright on positive BTK degrader data
Seeking Alpha 01:14 Tracking Baker Brothers Portfolio – Q1 2025 Update
Investing 20:12 Nurix Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Investing 13:58 Nurix stock price target reiterated at $30 by UBS on positive trial data
Investing 13:52 Nurix stock price target raised to $28 from $27 at RBC Capital
Investing 11:16 Nurix Therapeutics Presents Updated Positive Data Demonstrating Durable, Deepening Responses in Ongoing Clinical Trial of Bexobrutideg (NX-5948) Monotherapy in Patients with Relapsed/Refractory Chroni
Investing 11:13 Nurix Therapeutics to Host a Webcast Conference Call to Discuss Data from the Ongoing Phase 1 Clinical Trial of Bexobrutideg (NX-5948) Being Presented at the 30th European Hematology Association Congr
Investing 11:18 Stifel analysts maintain Buy rating on Nurix stock after SNY deal
Investing 14:31 UnitedHealth, Biontech lead Monday’s market cap stock movers
Investing 12:36 Sanofi extends license option with Nurix’s STAT6 program
Benzinga 12:12 Sanofi Expands Rare Immunology Portfolio With Blueprint Buyout - Nurix Therapeutics (NASDAQ:NRIX), Blueprint Medicines (NASDAQ:BPMC), Sanofi (NASDAQ:SNY)
Investing 11:08 Nurix secures additional $15 million from Sanofi license deal
Investing 11:24 Nurix Therapeutics to Participate in the Jefferies Global Healthcare Conference
Investing 20:19 Nurix Therapeutics reports stockholder voting results
Investing 20:16 Nurix Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Investing 11:24 Nurix Therapeutics to Participate in the RBC Capital Markets Global Healthcare Conference

Faixa diária

12.06 12.60

Faixa anual

8.18 29.56

Fechamento anterior: 12.15
Open: 12.34

Bid: 12.42
Ask: 12.72

Low: 12.06
High: 12.60

Volume: 1.761 K

Mudança diária: 0.65%
Mudança mensal: 9.04%

Mudança de 6 meses: -36.01%
Mudança anual: -43.55%

17 julho, quinta-feira